Rockwell Medical, Inc.
RMTI
$7.96
-$0.11-1.30%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.63% | -8.34% | -25.62% | -43.75% | -37.79% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.63% | -8.34% | -25.62% | -43.75% | -37.79% |
| Cost of Revenue | 7.14% | -9.03% | -31.22% | -38.15% | -36.25% |
| Gross Profit | 29.56% | -4.77% | 6.80% | -63.58% | -44.99% |
| SG&A Expenses | 10.70% | -0.57% | 3.06% | -10.39% | -4.54% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.16% | -7.19% | -25.57% | -33.62% | -31.19% |
| Operating Income | 21.35% | -8.82% | 23.31% | -181.82% | -361.94% |
| Income Before Tax | 21.45% | -5.94% | 26.72% | -205.35% | -534.99% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 21.45% | -5.94% | 26.72% | -205.35% | -534.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 21.45% | -5.94% | 26.72% | -205.35% | -534.99% |
| EBIT | 21.35% | -8.82% | 23.31% | -181.82% | -361.94% |
| EBITDA | 27.61% | -18.03% | 516.67% | -141.95% | -173.87% |
| EPS Basic | 30.08% | 8.33% | 54.59% | -207.30% | -612.18% |
| Normalized Basic EPS | 27.45% | 5.00% | 31.47% | -195.48% | -573.12% |
| EPS Diluted | 30.08% | 8.33% | 54.73% | -225.00% | -612.18% |
| Normalized Diluted EPS | 27.45% | 5.00% | 31.47% | -198.10% | -597.19% |
| Average Basic Shares Outstanding | 15.37% | 15.57% | 19.85% | 14.18% | 12.67% |
| Average Diluted Shares Outstanding | 15.37% | 15.57% | 19.85% | 11.12% | 7.11% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |